Supplemental Guarantor Information (Details) (USD $) | 3 Months Ended | 6 Months Ended | |
In Millions, unless otherwise specified | Jun. 30, 2014 | Jun. 30, 2013 | Jun. 30, 2014 | Jun. 30, 2013 | Dec. 31, 2013 |
Condensed Consolidating Statements of Operations and Comprehensive (Loss) Income | ' | ' | ' | ' | ' |
Revenue | $319.90 | $312 | $642.40 | $637.70 | ' |
Operating costs and expenses | 284.3 | 265.2 | 549.9 | 571.7 | ' |
Operating (loss) income | 35.6 | 46.8 | 92.5 | 66 | ' |
Interest expense (income), net | 40.7 | 45.4 | 81 | 93.3 | ' |
Other (income) expense, net | 0.1 | 0.1 | 0.7 | -0.2 | ' |
Income (loss) before equity in earnings of subsidiaries and income taxes | 185.2 | -3.4 | 201.7 | -33.7 | ' |
Income tax expense (benefit) | 71 | -4.2 | 80.5 | 2.2 | ' |
Net income (loss) | 114.2 | 0.8 | 121.2 | -35.9 | ' |
Total comprehensive income (loss) | 114.8 | 9.8 | 123.6 | -24.3 | ' |
Preferred stock dividends | 2.6 | 2.6 | 5.2 | 5.2 | ' |
Net income (loss) applicable to common shareowners | 111.6 | -1.8 | 116 | -41.1 | ' |
Condensed Consolidating Balance Sheets | ' | ' | ' | ' | ' |
Cash and cash equivalents | 347.2 | 5.5 | 347.2 | 5.5 | ' |
Other current assets | 0.7 | ' | 0.7 | ' | 1.6 |
Total current assets | 608.3 | ' | 608.3 | ' | 251.1 |
Property, plant and equipment, net | 874.7 | ' | 874.7 | ' | 902.8 |
Investment in CyrusOne | 290.7 | ' | 290.7 | ' | 471 |
Other noncurrent assets | 38.8 | ' | 38.8 | ' | 36.6 |
Total assets | 2,176.90 | ' | 2,176.90 | ' | 2,107.30 |
Current portion of long-term debt | 12.1 | ' | 12.1 | ' | 12.6 |
Accounts payable | 105.1 | ' | 105.1 | ' | 89.4 |
Other current liabilities | 36.2 | ' | 36.2 | ' | 36.8 |
Total current liabilities | 270.6 | ' | 270.6 | ' | 254.3 |
Long-term debt, less current portion | 2,214.20 | ' | 2,214.20 | ' | 2,252.60 |
Other noncurrent liabilities | 62.7 | ' | 62.7 | ' | 74.4 |
Total liabilities | 2,732.90 | ' | 2,732.90 | ' | 2,784 |
Shareowners' (deficit) equity | -556 | ' | -556 | ' | -676.7 |
Total liabilities and shareowners' equity (deficit) | 2,176.90 | ' | 2,176.90 | ' | 2,107.30 |
Condensed Consolidating Statements of Cash Flows | ' | ' | ' | ' | ' |
Cash flows (used in) provided by operating activities | ' | ' | 93.8 | 29.4 | ' |
Capital expenditures | -41.2 | -45 | -75.5 | -95.9 | ' |
Proceeds from Sale of CyrusOne | ' | ' | 355.9 | 0 | ' |
Dividends received from CyrusOne | 9.3 | ' | 16.4 | 7 | ' |
Proceeds from sale of assets | ' | ' | 2 | 1.6 | ' |
Cash divested from deconsolidation of CyrusOne | ' | ' | 0 | -12.2 | ' |
Other investing activities | ' | ' | -5.7 | 0 | ' |
Cash flows used in investing activities | ' | ' | 293.1 | -99.1 | ' |
Borrowings on revolving facilities, net | ' | ' | -31.4 | 56.8 | ' |
Repayment of debt | ' | ' | -8.3 | -4.8 | ' |
Proceeds from exercise of options and warrants | ' | ' | 1.2 | 6.6 | ' |
Other financing activities | ' | ' | -1.4 | -2.3 | ' |
Cash flows provided by (used in) financing activities | ' | ' | -44.3 | 51.6 | ' |
(Decrease) increase in cash and cash equivalents | ' | ' | 342.6 | -18.1 | ' |
Cash and cash equivalents at beginning of period | ' | ' | 4.6 | 23.6 | ' |
Cash and cash equivalents at end of period | 347.2 | 5.5 | 347.2 | 5.5 | ' |
Notes guaranteed by parent [Member] | ' | ' | ' | ' | ' |
Condensed Consolidating Statements of Operations and Comprehensive (Loss) Income | ' | ' | ' | ' | ' |
Revenue | 319.9 | 312 | 642.4 | 637.7 | ' |
Operating costs and expenses | 284.3 | 265.2 | 549.9 | 571.7 | ' |
Operating (loss) income | 35.6 | 46.8 | 92.5 | 66 | ' |
Interest expense (income), net | 40.7 | 45.4 | 81 | 93.3 | ' |
Other (income) expense, net | -190.3 | 4.8 | -190.2 | 6.4 | ' |
Income (loss) before equity in earnings of subsidiaries and income taxes | 185.2 | -3.4 | 201.7 | -33.7 | ' |
Income tax expense (benefit) | 71 | -4.2 | 80.5 | 2.2 | ' |
Equity in earnings of subsidiaries, net of tax | 0 | 0 | 0 | 0 | ' |
Net income (loss) | 114.2 | 0.8 | 121.2 | -35.9 | ' |
Other comprehensive income (loss) | 0.6 | 9 | 2.4 | 11.6 | ' |
Total comprehensive income (loss) | 114.8 | 9.8 | 123.6 | -24.3 | ' |
Preferred stock dividends | 2.6 | 2.6 | 5.2 | 5.2 | ' |
Net income (loss) applicable to common shareowners | 111.6 | -1.8 | 116 | -41.1 | ' |
Condensed Consolidating Balance Sheets | ' | ' | ' | ' | ' |
Cash and cash equivalents | 347.2 | 5.5 | 347.2 | 5.5 | ' |
Receivables, net | 170 | ' | 170 | ' | 154.8 |
Other current assets | 91.1 | ' | 91.1 | ' | 91.7 |
Total current assets | 608.3 | ' | 608.3 | ' | 251.1 |
Property, plant and equipment, net | 874.7 | ' | 874.7 | ' | 902.8 |
Investment in CyrusOne | 290.7 | ' | 290.7 | ' | 471 |
Goodwill and intangibles, net | 104.9 | ' | 104.9 | ' | 106.1 |
Investments in and advances to subsidiaries | 0 | ' | 0 | ' | 0 |
Other noncurrent assets | 298.3 | ' | 298.3 | ' | 376.3 |
Total assets | 2,176.90 | ' | 2,176.90 | ' | 2,107.30 |
Current portion of long-term debt | 12.1 | ' | 12.1 | ' | 12.6 |
Accounts payable | 105.4 | ' | 105.4 | ' | 89.9 |
Other current liabilities | 153.1 | ' | 153.1 | ' | 151.8 |
Total current liabilities | 270.6 | ' | 270.6 | ' | 254.3 |
Long-term debt, less current portion | 2,214.20 | ' | 2,214.20 | ' | 2,252.60 |
Other noncurrent liabilities | 248.1 | ' | 248.1 | ' | 277.1 |
Intercompany payables | 0 | ' | 0 | ' | 0 |
Total liabilities | 2,732.90 | ' | 2,732.90 | ' | 2,784 |
Shareowners' (deficit) equity | -556 | ' | -556 | ' | -676.7 |
Total liabilities and shareowners' equity (deficit) | 2,176.90 | ' | 2,176.90 | ' | 2,107.30 |
Condensed Consolidating Statements of Cash Flows | ' | ' | ' | ' | ' |
Cash flows (used in) provided by operating activities | ' | ' | 93.8 | 29.4 | ' |
Capital expenditures | ' | ' | -75.5 | -95.9 | ' |
Proceeds from Sale of CyrusOne | ' | ' | 355.9 | ' | ' |
Dividends received from CyrusOne | ' | ' | 16.4 | 7 | ' |
Proceeds from sale of assets | ' | ' | 2 | 1.6 | ' |
Cash divested from deconsolidation of CyrusOne | ' | ' | ' | -12.2 | ' |
Other investing activities | ' | ' | -5.7 | 0.4 | ' |
Cash flows used in investing activities | ' | ' | 293.1 | -99.1 | ' |
Funding between Parent and subsidiaries, net | ' | ' | 0 | 0 | ' |
Borrowings on revolving facilities, net | ' | ' | -31.4 | 56.8 | ' |
Repayment of debt | ' | ' | -8.3 | -4.8 | ' |
Proceeds from exercise of options and warrants | ' | ' | 1.2 | 6.6 | ' |
Other financing activities | ' | ' | -5.8 | -7 | ' |
Cash flows provided by (used in) financing activities | ' | ' | -44.3 | 51.6 | ' |
(Decrease) increase in cash and cash equivalents | ' | ' | 342.6 | -18.1 | ' |
Cash and cash equivalents at beginning of period | ' | ' | 4.6 | 23.6 | ' |
Cash and cash equivalents at end of period | 347.2 | 5.5 | 347.2 | 5.5 | ' |
Notes guaranteed by parent [Member] | Parent Company [Member] | ' | ' | ' | ' | ' |
Condensed Consolidating Statements of Operations and Comprehensive (Loss) Income | ' | ' | ' | ' | ' |
Revenue | 0 | 0 | 0 | 0 | ' |
Operating costs and expenses | 4.8 | 13.6 | 10.9 | 49.7 | ' |
Operating (loss) income | -4.8 | -13.6 | -10.9 | -49.7 | ' |
Interest expense (income), net | 37.9 | 46.3 | 75 | 82.1 | ' |
Other (income) expense, net | -0.4 | -0.3 | -0.7 | -0.7 | ' |
Income (loss) before equity in earnings of subsidiaries and income taxes | -42.3 | -59.6 | -85.2 | -131.1 | ' |
Income tax expense (benefit) | -11 | -21.2 | -22.5 | -41.3 | ' |
Equity in earnings of subsidiaries, net of tax | 145.5 | 39.2 | 183.9 | 53.9 | ' |
Net income (loss) | 114.2 | 0.8 | 121.2 | -35.9 | ' |
Other comprehensive income (loss) | 0.6 | 8.9 | 2.4 | 11.7 | ' |
Total comprehensive income (loss) | 114.8 | 9.7 | 123.6 | -24.2 | ' |
Preferred stock dividends | 2.6 | 2.6 | 5.2 | 5.2 | ' |
Net income (loss) applicable to common shareowners | 111.6 | -1.8 | 116 | -41.1 | ' |
Condensed Consolidating Balance Sheets | ' | ' | ' | ' | ' |
Cash and cash equivalents | 344.3 | 3.3 | 344.3 | 3.3 | ' |
Receivables, net | 2 | ' | 2 | ' | 2.6 |
Other current assets | 25.2 | ' | 25.2 | ' | 4.4 |
Total current assets | 371.5 | ' | 371.5 | ' | 9.1 |
Property, plant and equipment, net | 0.1 | ' | 0.1 | ' | 0.1 |
Investment in CyrusOne | 0 | ' | 0 | ' | 0 |
Goodwill and intangibles, net | 0 | ' | 0 | ' | 0 |
Investments in and advances to subsidiaries | 1,240.30 | ' | 1,240.30 | ' | 1,406.60 |
Other noncurrent assets | 279 | ' | 279 | ' | 359.1 |
Total assets | 1,890.90 | ' | 1,890.90 | ' | 1,774.90 |
Current portion of long-term debt | 5.4 | ' | 5.4 | ' | 5.4 |
Accounts payable | 0.3 | ' | 0.3 | ' | 1.5 |
Other current liabilities | 68.4 | ' | 68.4 | ' | 67.7 |
Total current liabilities | 74.1 | ' | 74.1 | ' | 74.6 |
Long-term debt, less current portion | 1,874.20 | ' | 1,874.20 | ' | 1,916.10 |
Other noncurrent liabilities | 197.8 | ' | 197.8 | ' | 214.5 |
Intercompany payables | 300.8 | ' | 300.8 | ' | 246.4 |
Total liabilities | 2,446.90 | ' | 2,446.90 | ' | 2,451.60 |
Shareowners' (deficit) equity | -556 | ' | -556 | ' | -676.7 |
Total liabilities and shareowners' equity (deficit) | 1,890.90 | ' | 1,890.90 | ' | 1,774.90 |
Condensed Consolidating Statements of Cash Flows | ' | ' | ' | ' | ' |
Cash flows (used in) provided by operating activities | ' | ' | -15 | -123.1 | ' |
Capital expenditures | ' | ' | 0 | 0 | ' |
Proceeds from Sale of CyrusOne | ' | ' | 0 | ' | ' |
Dividends received from CyrusOne | ' | ' | 0 | 0 | ' |
Proceeds from sale of assets | ' | ' | 0 | 0 | ' |
Cash divested from deconsolidation of CyrusOne | ' | ' | ' | 0 | ' |
Other investing activities | ' | ' | -0.2 | 0 | ' |
Cash flows used in investing activities | ' | ' | -0.2 | 0 | ' |
Funding between Parent and subsidiaries, net | ' | ' | 404.7 | 115 | ' |
Borrowings on revolving facilities, net | ' | ' | -40 | 8 | ' |
Repayment of debt | ' | ' | -2.7 | 0 | ' |
Proceeds from exercise of options and warrants | ' | ' | 1.2 | 6.6 | ' |
Other financing activities | ' | ' | -5.8 | -7 | ' |
Cash flows provided by (used in) financing activities | ' | ' | 357.4 | 122.6 | ' |
(Decrease) increase in cash and cash equivalents | ' | ' | 342.2 | -0.5 | ' |
Cash and cash equivalents at beginning of period | ' | ' | 2.1 | 3.8 | ' |
Cash and cash equivalents at end of period | 344.3 | 3.3 | 344.3 | 3.3 | ' |
Notes guaranteed by parent [Member] | Cincinnati Bell Telephone Company [Member] | ' | ' | ' | ' | ' |
Condensed Consolidating Statements of Operations and Comprehensive (Loss) Income | ' | ' | ' | ' | ' |
Revenue | 164.3 | 161.6 | 327.6 | 320.9 | ' |
Operating costs and expenses | 115.7 | 113.6 | 228.6 | 224.7 | ' |
Operating (loss) income | 48.6 | 48 | 99 | 96.2 | ' |
Interest expense (income), net | -1 | -5.6 | -1.8 | -1.1 | ' |
Other (income) expense, net | 2 | 0.9 | 3.9 | 2.6 | ' |
Income (loss) before equity in earnings of subsidiaries and income taxes | 47.6 | 52.7 | 96.9 | 94.7 | ' |
Income tax expense (benefit) | 17.3 | 18.3 | 35.4 | 34.8 | ' |
Equity in earnings of subsidiaries, net of tax | 0 | 0 | 0 | 0 | ' |
Net income (loss) | 30.3 | 34.4 | 61.5 | 59.9 | ' |
Other comprehensive income (loss) | 0 | 0 | 0 | 0 | ' |
Total comprehensive income (loss) | 30.3 | 34.4 | 61.5 | 59.9 | ' |
Preferred stock dividends | 0 | 0 | 0 | 0 | ' |
Net income (loss) applicable to common shareowners | 30.3 | 34.4 | 61.5 | 59.9 | ' |
Condensed Consolidating Balance Sheets | ' | ' | ' | ' | ' |
Cash and cash equivalents | 1.8 | 1.3 | 1.8 | 1.3 | ' |
Receivables, net | 0 | ' | 0 | ' | 0 |
Other current assets | 24.2 | ' | 24.2 | ' | 24.1 |
Total current assets | 26 | ' | 26 | ' | 25.9 |
Property, plant and equipment, net | 718.8 | ' | 718.8 | ' | 706.5 |
Investment in CyrusOne | 0 | ' | 0 | ' | 0 |
Goodwill and intangibles, net | 2.2 | ' | 2.2 | ' | 2.3 |
Investments in and advances to subsidiaries | 309.4 | ' | 309.4 | ' | 247.7 |
Other noncurrent assets | 5.5 | ' | 5.5 | ' | 6.1 |
Total assets | 1,061.90 | ' | 1,061.90 | ' | 988.5 |
Current portion of long-term debt | 3.5 | ' | 3.5 | ' | 3.9 |
Accounts payable | 56.1 | ' | 56.1 | ' | 45.9 |
Other current liabilities | 51.4 | ' | 51.4 | ' | 49.4 |
Total current liabilities | 111 | ' | 111 | ' | 99.2 |
Long-term debt, less current portion | 139.7 | ' | 139.7 | ' | 141.8 |
Other noncurrent liabilities | 174.4 | ' | 174.4 | ' | 172.2 |
Intercompany payables | 0 | ' | 0 | ' | 0 |
Total liabilities | 425.1 | ' | 425.1 | ' | 413.2 |
Shareowners' (deficit) equity | 636.8 | ' | 636.8 | ' | 575.3 |
Total liabilities and shareowners' equity (deficit) | 1,061.90 | ' | 1,061.90 | ' | 988.5 |
Condensed Consolidating Statements of Cash Flows | ' | ' | ' | ' | ' |
Cash flows (used in) provided by operating activities | ' | ' | 120.9 | 106.6 | ' |
Capital expenditures | ' | ' | -57.4 | -69.3 | ' |
Proceeds from Sale of CyrusOne | ' | ' | 0 | ' | ' |
Dividends received from CyrusOne | ' | ' | 0 | 0 | ' |
Proceeds from sale of assets | ' | ' | 0.2 | 1.6 | ' |
Cash divested from deconsolidation of CyrusOne | ' | ' | ' | 0 | ' |
Other investing activities | ' | ' | 0 | 0 | ' |
Cash flows used in investing activities | ' | ' | -57.2 | -67.7 | ' |
Funding between Parent and subsidiaries, net | ' | ' | -61.7 | -37.9 | ' |
Borrowings on revolving facilities, net | ' | ' | 0 | 0 | ' |
Repayment of debt | ' | ' | -2 | -1.6 | ' |
Proceeds from exercise of options and warrants | ' | ' | 0 | 0 | ' |
Other financing activities | ' | ' | 0 | 0 | ' |
Cash flows provided by (used in) financing activities | ' | ' | -63.7 | -39.5 | ' |
(Decrease) increase in cash and cash equivalents | ' | ' | 0 | -0.6 | ' |
Cash and cash equivalents at beginning of period | ' | ' | 1.8 | 1.9 | ' |
Cash and cash equivalents at end of period | 1.8 | 1.3 | 1.8 | 1.3 | ' |
Notes guaranteed by parent [Member] | Non-Guarantor Subsidiaries [Member] | ' | ' | ' | ' | ' |
Condensed Consolidating Statements of Operations and Comprehensive (Loss) Income | ' | ' | ' | ' | ' |
Revenue | 170 | 164.4 | 343.6 | 344.9 | ' |
Operating costs and expenses | 178.2 | 152 | 339.2 | 325.4 | ' |
Operating (loss) income | -8.2 | 12.4 | 4.4 | 19.5 | ' |
Interest expense (income), net | 3.8 | 4.7 | 7.8 | 12.3 | ' |
Other (income) expense, net | -191.9 | 4.2 | -193.4 | 4.5 | ' |
Income (loss) before equity in earnings of subsidiaries and income taxes | 179.9 | 3.5 | 190 | 2.7 | ' |
Income tax expense (benefit) | 64.7 | -1.3 | 67.6 | 8.7 | ' |
Equity in earnings of subsidiaries, net of tax | 0 | 0 | 0 | 0 | ' |
Net income (loss) | 115.2 | 4.8 | 122.4 | -6 | ' |
Other comprehensive income (loss) | 0 | 0.1 | 0 | -0.1 | ' |
Total comprehensive income (loss) | 115.2 | 4.9 | 122.4 | -6.1 | ' |
Preferred stock dividends | 0 | 0 | 0 | 0 | ' |
Net income (loss) applicable to common shareowners | 115.2 | 4.8 | 122.4 | -6 | ' |
Condensed Consolidating Balance Sheets | ' | ' | ' | ' | ' |
Cash and cash equivalents | 1.1 | 0.9 | 1.1 | 0.9 | ' |
Receivables, net | 168 | ' | 168 | ' | 152.2 |
Other current assets | 42 | ' | 42 | ' | 63.9 |
Total current assets | 211.1 | ' | 211.1 | ' | 216.8 |
Property, plant and equipment, net | 155.8 | ' | 155.8 | ' | 196.2 |
Investment in CyrusOne | 290.7 | ' | 290.7 | ' | 471 |
Goodwill and intangibles, net | 102.7 | ' | 102.7 | ' | 103.8 |
Investments in and advances to subsidiaries | 139.8 | ' | 139.8 | ' | 0 |
Other noncurrent assets | 168.4 | ' | 168.4 | ' | 178.9 |
Total assets | 1,068.50 | ' | 1,068.50 | ' | 1,166.70 |
Current portion of long-term debt | 3.2 | ' | 3.2 | ' | 3.3 |
Accounts payable | 49 | ' | 49 | ' | 42.5 |
Other current liabilities | 33.3 | ' | 33.3 | ' | 34.6 |
Total current liabilities | 85.5 | ' | 85.5 | ' | 80.4 |
Long-term debt, less current portion | 200.3 | ' | 200.3 | ' | 194.7 |
Other noncurrent liabilities | 30.8 | ' | 30.8 | ' | 59 |
Intercompany payables | 0 | ' | 0 | ' | 199.7 |
Total liabilities | 316.6 | ' | 316.6 | ' | 533.8 |
Shareowners' (deficit) equity | 751.9 | ' | 751.9 | ' | 632.9 |
Total liabilities and shareowners' equity (deficit) | 1,068.50 | ' | 1,068.50 | ' | 1,166.70 |
Condensed Consolidating Statements of Cash Flows | ' | ' | ' | ' | ' |
Cash flows (used in) provided by operating activities | ' | ' | -12.1 | 45.9 | ' |
Capital expenditures | ' | ' | -18.1 | -26.6 | ' |
Proceeds from Sale of CyrusOne | ' | ' | 355.9 | ' | ' |
Dividends received from CyrusOne | ' | ' | 16.4 | 7 | ' |
Proceeds from sale of assets | ' | ' | 1.8 | 0 | ' |
Cash divested from deconsolidation of CyrusOne | ' | ' | ' | -12.2 | ' |
Other investing activities | ' | ' | -5.5 | 0.4 | ' |
Cash flows used in investing activities | ' | ' | 350.5 | -31.4 | ' |
Funding between Parent and subsidiaries, net | ' | ' | -343 | -77.1 | ' |
Borrowings on revolving facilities, net | ' | ' | 8.6 | 48.8 | ' |
Repayment of debt | ' | ' | -3.6 | -3.2 | ' |
Proceeds from exercise of options and warrants | ' | ' | 0 | 0 | ' |
Other financing activities | ' | ' | 0 | 0 | ' |
Cash flows provided by (used in) financing activities | ' | ' | -338 | -31.5 | ' |
(Decrease) increase in cash and cash equivalents | ' | ' | 0.4 | -17 | ' |
Cash and cash equivalents at beginning of period | ' | ' | 0.7 | 17.9 | ' |
Cash and cash equivalents at end of period | 1.1 | 0.9 | 1.1 | 0.9 | ' |
Notes guaranteed by parent [Member] | Consolidation, Eliminations [Member] | ' | ' | ' | ' | ' |
Condensed Consolidating Statements of Operations and Comprehensive (Loss) Income | ' | ' | ' | ' | ' |
Revenue | -14.4 | -14 | -28.8 | -28.1 | ' |
Operating costs and expenses | -14.4 | -14 | -28.8 | -28.1 | ' |
Operating (loss) income | 0 | 0 | 0 | 0 | ' |
Interest expense (income), net | 0 | 0 | 0 | 0 | ' |
Other (income) expense, net | 0 | 0 | 0 | 0 | ' |
Income (loss) before equity in earnings of subsidiaries and income taxes | 0 | 0 | 0 | 0 | ' |
Income tax expense (benefit) | 0 | 0 | 0 | 0 | ' |
Equity in earnings of subsidiaries, net of tax | -145.5 | -39.2 | -183.9 | -53.9 | ' |
Net income (loss) | -145.5 | -39.2 | -183.9 | -53.9 | ' |
Other comprehensive income (loss) | 0 | 0 | 0 | 0 | ' |
Total comprehensive income (loss) | -145.5 | -39.2 | -183.9 | -53.9 | ' |
Preferred stock dividends | 0 | 0 | 0 | 0 | ' |
Net income (loss) applicable to common shareowners | -145.5 | -39.2 | -183.9 | -53.9 | ' |
Condensed Consolidating Balance Sheets | ' | ' | ' | ' | ' |
Cash and cash equivalents | 0 | 0 | 0 | 0 | ' |
Receivables, net | 0 | ' | 0 | ' | 0 |
Other current assets | -0.3 | ' | -0.3 | ' | -0.7 |
Total current assets | -0.3 | ' | -0.3 | ' | -0.7 |
Property, plant and equipment, net | 0 | ' | 0 | ' | 0 |
Investment in CyrusOne | 0 | ' | 0 | ' | 0 |
Goodwill and intangibles, net | 0 | ' | 0 | ' | 0 |
Investments in and advances to subsidiaries | -1,689.50 | ' | -1,689.50 | ' | -1,654.30 |
Other noncurrent assets | -154.6 | ' | -154.6 | ' | -167.8 |
Total assets | -1,844.40 | ' | -1,844.40 | ' | -1,822.80 |
Current portion of long-term debt | 0 | ' | 0 | ' | 0 |
Accounts payable | 0 | ' | 0 | ' | 0 |
Other current liabilities | 0 | ' | 0 | ' | 0.1 |
Total current liabilities | 0 | ' | 0 | ' | 0.1 |
Long-term debt, less current portion | 0 | ' | 0 | ' | 0 |
Other noncurrent liabilities | -154.9 | ' | -154.9 | ' | -168.6 |
Intercompany payables | -300.8 | ' | -300.8 | ' | -446.1 |
Total liabilities | -455.7 | ' | -455.7 | ' | -614.6 |
Shareowners' (deficit) equity | -1,388.70 | ' | -1,388.70 | ' | -1,208.20 |
Total liabilities and shareowners' equity (deficit) | -1,844.40 | ' | -1,844.40 | ' | -1,822.80 |
Condensed Consolidating Statements of Cash Flows | ' | ' | ' | ' | ' |
Cash flows (used in) provided by operating activities | ' | ' | 0 | 0 | ' |
Capital expenditures | ' | ' | 0 | 0 | ' |
Proceeds from Sale of CyrusOne | ' | ' | 0 | ' | ' |
Dividends received from CyrusOne | ' | ' | 0 | 0 | ' |
Proceeds from sale of assets | ' | ' | 0 | 0 | ' |
Cash divested from deconsolidation of CyrusOne | ' | ' | ' | 0 | ' |
Other investing activities | ' | ' | 0 | 0 | ' |
Cash flows used in investing activities | ' | ' | 0 | 0 | ' |
Funding between Parent and subsidiaries, net | ' | ' | 0 | 0 | ' |
Borrowings on revolving facilities, net | ' | ' | 0 | 0 | ' |
Repayment of debt | ' | ' | 0 | 0 | ' |
Proceeds from exercise of options and warrants | ' | ' | 0 | 0 | ' |
Other financing activities | ' | ' | 0 | 0 | ' |
Cash flows provided by (used in) financing activities | ' | ' | 0 | 0 | ' |
(Decrease) increase in cash and cash equivalents | ' | ' | 0 | 0 | ' |
Cash and cash equivalents at beginning of period | ' | ' | 0 | 0 | ' |
Cash and cash equivalents at end of period | 0 | 0 | 0 | 0 | ' |
Notes guaranteed by subsidiaries [Member] | ' | ' | ' | ' | ' |
Condensed Consolidating Statements of Operations and Comprehensive (Loss) Income | ' | ' | ' | ' | ' |
Revenue | 319.9 | 312 | 642.4 | 637.7 | ' |
Operating costs and expenses | 284.3 | 265.2 | 549.9 | 571.7 | ' |
Operating (loss) income | 35.6 | 46.8 | 92.5 | 66 | ' |
Interest expense (income), net | 40.7 | 45.4 | 81 | 93.3 | ' |
Other (income) expense, net | -190.3 | 4.8 | -190.2 | 6.4 | ' |
Income (loss) before equity in earnings of subsidiaries and income taxes | 185.2 | -3.4 | 201.7 | -33.7 | ' |
Income tax expense (benefit) | 71 | -4.2 | 80.5 | 2.2 | ' |
Equity in earnings of subsidiaries, net of tax | 0 | 0 | 0 | 0 | ' |
Net income (loss) | 114.2 | 0.8 | 121.2 | -35.9 | ' |
Other comprehensive income (loss) | 0.6 | 9 | 2.4 | 11.6 | ' |
Total comprehensive income (loss) | 114.8 | 9.8 | 123.6 | -24.3 | ' |
Preferred stock dividends | 2.6 | 2.6 | 5.2 | 5.2 | ' |
Net income (loss) applicable to common shareowners | 111.6 | -1.8 | 116 | -41.1 | ' |
Condensed Consolidating Balance Sheets | ' | ' | ' | ' | ' |
Cash and cash equivalents | 347.2 | 5.5 | 347.2 | 5.5 | ' |
Receivables, net | 170 | ' | 170 | ' | 154.8 |
Other current assets | 91.1 | ' | 91.1 | ' | 91.7 |
Total current assets | 608.3 | ' | 608.3 | ' | 251.1 |
Property, plant and equipment, net | 874.7 | ' | 874.7 | ' | 902.8 |
Investment in CyrusOne | 290.7 | ' | 290.7 | ' | 471 |
Goodwill and intangibles, net | 104.9 | ' | 104.9 | ' | 106.1 |
Investments in and advances to subsidiaries | 0 | ' | 0 | ' | 0 |
Other noncurrent assets | 298.3 | ' | 298.3 | ' | 376.3 |
Total assets | 2,176.90 | ' | 2,176.90 | ' | 2,107.30 |
Current portion of long-term debt | 12.1 | ' | 12.1 | ' | 12.6 |
Accounts payable | 105.4 | ' | 105.4 | ' | 89.9 |
Other current liabilities | 153.1 | ' | 153.1 | ' | 151.8 |
Total current liabilities | 270.6 | ' | 270.6 | ' | 254.3 |
Long-term debt, less current portion | 2,214.20 | ' | 2,214.20 | ' | 2,252.60 |
Other noncurrent liabilities | 248.1 | ' | 248.1 | ' | 277.1 |
Intercompany payables | 0 | ' | 0 | ' | 0 |
Total liabilities | 2,732.90 | ' | 2,732.90 | ' | 2,784 |
Shareowners' (deficit) equity | -556 | ' | -556 | ' | -676.7 |
Total liabilities and shareowners' equity (deficit) | 2,176.90 | ' | 2,176.90 | ' | 2,107.30 |
Condensed Consolidating Statements of Cash Flows | ' | ' | ' | ' | ' |
Cash flows (used in) provided by operating activities | ' | ' | 93.8 | 29.4 | ' |
Capital expenditures | ' | ' | -75.5 | -95.9 | ' |
Proceeds from Sale of CyrusOne | ' | ' | 355.9 | ' | ' |
Dividends received from CyrusOne | ' | ' | 16.4 | 7 | ' |
Proceeds from sale of assets | ' | ' | 2 | 1.6 | ' |
Cash divested from deconsolidation of CyrusOne | ' | ' | ' | -12.2 | ' |
Other investing activities | ' | ' | -5.7 | 0.4 | ' |
Cash flows used in investing activities | ' | ' | 293.1 | -99.1 | ' |
Funding between Parent and subsidiaries, net | ' | ' | 0 | 0 | ' |
Borrowings on revolving facilities, net | ' | ' | -31.4 | 56.8 | ' |
Repayment of debt | ' | ' | -8.3 | -4.8 | ' |
Proceeds from exercise of options and warrants | ' | ' | 1.2 | 6.6 | ' |
Other financing activities | ' | ' | -5.8 | -7 | ' |
Cash flows provided by (used in) financing activities | ' | ' | -44.3 | 51.6 | ' |
(Decrease) increase in cash and cash equivalents | ' | ' | 342.6 | -18.1 | ' |
Cash and cash equivalents at beginning of period | ' | ' | 4.6 | 23.6 | ' |
Cash and cash equivalents at end of period | 347.2 | 5.5 | 347.2 | 5.5 | ' |
Notes guaranteed by subsidiaries [Member] | Parent Company [Member] | ' | ' | ' | ' | ' |
Condensed Consolidating Statements of Operations and Comprehensive (Loss) Income | ' | ' | ' | ' | ' |
Revenue | 0 | 0 | 0 | 0 | ' |
Operating costs and expenses | 4.8 | 13.6 | 10.9 | 49.7 | ' |
Operating (loss) income | -4.8 | -13.6 | -10.9 | -49.7 | ' |
Interest expense (income), net | 37.9 | 46.3 | 75 | 82.1 | ' |
Other (income) expense, net | -0.4 | -0.3 | -0.7 | -0.7 | ' |
Income (loss) before equity in earnings of subsidiaries and income taxes | -42.3 | -59.6 | -85.2 | -131.1 | ' |
Income tax expense (benefit) | -11 | -21.2 | -22.5 | -41.3 | ' |
Equity in earnings of subsidiaries, net of tax | 145.5 | 39.2 | 183.9 | 53.9 | ' |
Net income (loss) | 114.2 | 0.8 | 121.2 | -35.9 | ' |
Other comprehensive income (loss) | 0.6 | 8.9 | 2.4 | 11.7 | ' |
Total comprehensive income (loss) | 114.8 | 9.7 | 123.6 | -24.2 | ' |
Preferred stock dividends | 2.6 | 2.6 | 5.2 | 5.2 | ' |
Net income (loss) applicable to common shareowners | 111.6 | -1.8 | 116 | -41.1 | ' |
Condensed Consolidating Balance Sheets | ' | ' | ' | ' | ' |
Cash and cash equivalents | 344.3 | 3.3 | 344.3 | 3.3 | ' |
Receivables, net | 2 | ' | 2 | ' | 2.6 |
Other current assets | 25.2 | ' | 25.2 | ' | 4.4 |
Total current assets | 371.5 | ' | 371.5 | ' | 9.1 |
Property, plant and equipment, net | 0.1 | ' | 0.1 | ' | 0.1 |
Investment in CyrusOne | 0 | ' | 0 | ' | 0 |
Goodwill and intangibles, net | 0 | ' | 0 | ' | 0 |
Investments in and advances to subsidiaries | 1,240.30 | ' | 1,240.30 | ' | 1,406.60 |
Other noncurrent assets | 279 | ' | 279 | ' | 359.1 |
Total assets | 1,890.90 | ' | 1,890.90 | ' | 1,774.90 |
Current portion of long-term debt | 5.4 | ' | 5.4 | ' | 5.4 |
Accounts payable | 0.3 | ' | 0.3 | ' | 1.5 |
Other current liabilities | 68.4 | ' | 68.4 | ' | 67.7 |
Total current liabilities | 74.1 | ' | 74.1 | ' | 74.6 |
Long-term debt, less current portion | 1,874.20 | ' | 1,874.20 | ' | 1,916.10 |
Other noncurrent liabilities | 197.8 | ' | 197.8 | ' | 214.5 |
Intercompany payables | 300.8 | ' | 300.8 | ' | 246.4 |
Total liabilities | 2,446.90 | ' | 2,446.90 | ' | 2,451.60 |
Shareowners' (deficit) equity | -556 | ' | -556 | ' | -676.7 |
Total liabilities and shareowners' equity (deficit) | 1,890.90 | ' | 1,890.90 | ' | 1,774.90 |
Condensed Consolidating Statements of Cash Flows | ' | ' | ' | ' | ' |
Cash flows (used in) provided by operating activities | ' | ' | -15 | -123.1 | ' |
Capital expenditures | ' | ' | 0 | 0 | ' |
Proceeds from Sale of CyrusOne | ' | ' | 0 | ' | ' |
Dividends received from CyrusOne | ' | ' | 0 | 0 | ' |
Proceeds from sale of assets | ' | ' | 0 | 0 | ' |
Cash divested from deconsolidation of CyrusOne | ' | ' | ' | 0 | ' |
Other investing activities | ' | ' | -0.2 | 0 | ' |
Cash flows used in investing activities | ' | ' | -0.2 | 0 | ' |
Funding between Parent and subsidiaries, net | ' | ' | 404.7 | 115 | ' |
Borrowings on revolving facilities, net | ' | ' | -40 | 8 | ' |
Repayment of debt | ' | ' | -2.7 | 0 | ' |
Proceeds from exercise of options and warrants | ' | ' | 1.2 | 6.6 | ' |
Other financing activities | ' | ' | -5.8 | -7 | ' |
Cash flows provided by (used in) financing activities | ' | ' | 357.4 | 122.6 | ' |
(Decrease) increase in cash and cash equivalents | ' | ' | 342.2 | -0.5 | ' |
Cash and cash equivalents at beginning of period | ' | ' | 2.1 | 3.8 | ' |
Cash and cash equivalents at end of period | 344.3 | 3.3 | 344.3 | 3.3 | ' |
Notes guaranteed by subsidiaries [Member] | Guarantor Subsidiaries [Member] | ' | ' | ' | ' | ' |
Condensed Consolidating Statements of Operations and Comprehensive (Loss) Income | ' | ' | ' | ' | ' |
Revenue | 183.2 | 177.6 | 370.3 | 353.3 | ' |
Operating costs and expenses | 190.3 | 163.5 | 363.2 | 333.6 | ' |
Operating (loss) income | -7.1 | 14.1 | 7.1 | 19.7 | ' |
Interest expense (income), net | 3.4 | 3.8 | 7 | 7.7 | ' |
Other (income) expense, net | -186.5 | 4.2 | -183 | 8.9 | ' |
Income (loss) before equity in earnings of subsidiaries and income taxes | 176 | 6.1 | 183.1 | 3.1 | ' |
Income tax expense (benefit) | 62.8 | -0.7 | 65.1 | 8.8 | ' |
Equity in earnings of subsidiaries, net of tax | 0 | 0 | 0 | 0.7 | ' |
Net income (loss) | 113.2 | 6.8 | 118 | -5 | ' |
Other comprehensive income (loss) | 0 | 0 | 0 | 0 | ' |
Total comprehensive income (loss) | 113.2 | 6.8 | 118 | -5 | ' |
Preferred stock dividends | 0 | 0 | 0 | 0 | ' |
Net income (loss) applicable to common shareowners | 113.2 | 6.8 | 118 | -5 | ' |
Condensed Consolidating Balance Sheets | ' | ' | ' | ' | ' |
Cash and cash equivalents | 0.6 | 0.7 | 0.6 | 0.7 | ' |
Receivables, net | 6 | ' | 6 | ' | 7.2 |
Other current assets | 37.9 | ' | 37.9 | ' | 60.7 |
Total current assets | 44.5 | ' | 44.5 | ' | 68.2 |
Property, plant and equipment, net | 155.4 | ' | 155.4 | ' | 194.1 |
Investment in CyrusOne | 290.7 | ' | 290.7 | ' | 471 |
Goodwill and intangibles, net | 102.7 | ' | 102.7 | ' | 103.8 |
Investments in and advances to subsidiaries | 178 | ' | 178 | ' | -1.6 |
Other noncurrent assets | 169.5 | ' | 169.5 | ' | 179.9 |
Total assets | 940.8 | ' | 940.8 | ' | 1,015.40 |
Current portion of long-term debt | 3.2 | ' | 3.2 | ' | 3 |
Accounts payable | 59.2 | ' | 59.2 | ' | 72.3 |
Other current liabilities | 36.7 | ' | 36.7 | ' | 36.9 |
Total current liabilities | 99.1 | ' | 99.1 | ' | 112.2 |
Long-term debt, less current portion | 85.6 | ' | 85.6 | ' | 87 |
Other noncurrent liabilities | 33.3 | ' | 33.3 | ' | 61.3 |
Intercompany payables | 0 | ' | 0 | ' | 149.9 |
Total liabilities | 218 | ' | 218 | ' | 410.4 |
Shareowners' (deficit) equity | 722.8 | ' | 722.8 | ' | 605 |
Total liabilities and shareowners' equity (deficit) | 940.8 | ' | 940.8 | ' | 1,015.40 |
Condensed Consolidating Statements of Cash Flows | ' | ' | ' | ' | ' |
Cash flows (used in) provided by operating activities | ' | ' | -17.5 | 13.1 | ' |
Capital expenditures | ' | ' | -18.1 | -18.9 | ' |
Proceeds from Sale of CyrusOne | ' | ' | 355.9 | ' | ' |
Dividends received from CyrusOne | ' | ' | 16.4 | 7 | ' |
Proceeds from sale of assets | ' | ' | 0 | 0 | ' |
Cash divested from deconsolidation of CyrusOne | ' | ' | ' | 0 | ' |
Other investing activities | ' | ' | -5.5 | 0 | ' |
Cash flows used in investing activities | ' | ' | 348.7 | -11.9 | ' |
Funding between Parent and subsidiaries, net | ' | ' | -329.5 | 1.5 | ' |
Borrowings on revolving facilities, net | ' | ' | 0 | 0 | ' |
Repayment of debt | ' | ' | -1.4 | -2.3 | ' |
Proceeds from exercise of options and warrants | ' | ' | 0 | 0 | ' |
Other financing activities | ' | ' | 0 | 0 | ' |
Cash flows provided by (used in) financing activities | ' | ' | -330.9 | -0.8 | ' |
(Decrease) increase in cash and cash equivalents | ' | ' | 0.3 | 0.4 | ' |
Cash and cash equivalents at beginning of period | ' | ' | 0.3 | 0.3 | ' |
Cash and cash equivalents at end of period | 0.6 | 0.7 | 0.6 | 0.7 | ' |
Notes guaranteed by subsidiaries [Member] | Non-Guarantor Subsidiaries [Member] | ' | ' | ' | ' | ' |
Condensed Consolidating Statements of Operations and Comprehensive (Loss) Income | ' | ' | ' | ' | ' |
Revenue | 151.1 | 148.4 | 300.9 | 312.5 | ' |
Operating costs and expenses | 103.6 | 102.1 | 204.6 | 216.5 | ' |
Operating (loss) income | 47.5 | 46.3 | 96.3 | 96 | ' |
Interest expense (income), net | -0.6 | -4.7 | -1 | 3.5 | ' |
Other (income) expense, net | -3.4 | 0.9 | -6.5 | -1.8 | ' |
Income (loss) before equity in earnings of subsidiaries and income taxes | 51.5 | 50.1 | 103.8 | 94.3 | ' |
Income tax expense (benefit) | 19.2 | 17.7 | 37.9 | 34.7 | ' |
Equity in earnings of subsidiaries, net of tax | 0 | 0 | 0 | 0 | ' |
Net income (loss) | 32.3 | 32.4 | 65.9 | 59.6 | ' |
Other comprehensive income (loss) | 0 | 0.1 | 0 | -0.1 | ' |
Total comprehensive income (loss) | 32.3 | 32.5 | 65.9 | 59.5 | ' |
Preferred stock dividends | 0 | 0 | 0 | 0 | ' |
Net income (loss) applicable to common shareowners | 32.3 | 32.4 | 65.9 | 59.6 | ' |
Condensed Consolidating Balance Sheets | ' | ' | ' | ' | ' |
Cash and cash equivalents | 2.3 | 1.5 | 2.3 | 1.5 | ' |
Receivables, net | 162 | ' | 162 | ' | 145 |
Other current assets | 28.3 | ' | 28.3 | ' | 27.3 |
Total current assets | 192.6 | ' | 192.6 | ' | 174.5 |
Property, plant and equipment, net | 719.2 | ' | 719.2 | ' | 708.6 |
Investment in CyrusOne | 0 | ' | 0 | ' | 0 |
Goodwill and intangibles, net | 2.2 | ' | 2.2 | ' | 2.3 |
Investments in and advances to subsidiaries | 294.7 | ' | 294.7 | ' | 218.2 |
Other noncurrent assets | 4.4 | ' | 4.4 | ' | 5.1 |
Total assets | 1,213.10 | ' | 1,213.10 | ' | 1,108.70 |
Current portion of long-term debt | 3.5 | ' | 3.5 | ' | 4.2 |
Accounts payable | 45.9 | ' | 45.9 | ' | 16.1 |
Other current liabilities | 48 | ' | 48 | ' | 47.1 |
Total current liabilities | 97.4 | ' | 97.4 | ' | 67.4 |
Long-term debt, less current portion | 254.4 | ' | 254.4 | ' | 249.5 |
Other noncurrent liabilities | 171.9 | ' | 171.9 | ' | 169.9 |
Intercompany payables | 36.2 | ' | 36.2 | ' | 33.2 |
Total liabilities | 559.9 | ' | 559.9 | ' | 520 |
Shareowners' (deficit) equity | 653.2 | ' | 653.2 | ' | 588.7 |
Total liabilities and shareowners' equity (deficit) | 1,213.10 | ' | 1,213.10 | ' | 1,108.70 |
Condensed Consolidating Statements of Cash Flows | ' | ' | ' | ' | ' |
Cash flows (used in) provided by operating activities | ' | ' | 126.3 | 139.4 | ' |
Capital expenditures | ' | ' | -57.4 | -77 | ' |
Proceeds from Sale of CyrusOne | ' | ' | 0 | ' | ' |
Dividends received from CyrusOne | ' | ' | 0 | 0 | ' |
Proceeds from sale of assets | ' | ' | 2 | 1.6 | ' |
Cash divested from deconsolidation of CyrusOne | ' | ' | ' | -12.2 | ' |
Other investing activities | ' | ' | 0 | -0.4 | ' |
Cash flows used in investing activities | ' | ' | -55.4 | -87.2 | ' |
Funding between Parent and subsidiaries, net | ' | ' | -75.2 | -116.5 | ' |
Borrowings on revolving facilities, net | ' | ' | 8.6 | 48.8 | ' |
Repayment of debt | ' | ' | -4.2 | -2.5 | ' |
Proceeds from exercise of options and warrants | ' | ' | 0 | 0 | ' |
Other financing activities | ' | ' | 0 | 0 | ' |
Cash flows provided by (used in) financing activities | ' | ' | -70.8 | -70.2 | ' |
(Decrease) increase in cash and cash equivalents | ' | ' | 0.1 | -18 | ' |
Cash and cash equivalents at beginning of period | ' | ' | 2.2 | 19.5 | ' |
Cash and cash equivalents at end of period | 2.3 | 1.5 | 2.3 | 1.5 | ' |
Notes guaranteed by subsidiaries [Member] | Consolidation, Eliminations [Member] | ' | ' | ' | ' | ' |
Condensed Consolidating Statements of Operations and Comprehensive (Loss) Income | ' | ' | ' | ' | ' |
Revenue | -14.4 | -14 | -28.8 | -28.1 | ' |
Operating costs and expenses | -14.4 | -14 | -28.8 | -28.1 | ' |
Operating (loss) income | 0 | 0 | 0 | 0 | ' |
Interest expense (income), net | 0 | 0 | 0 | 0 | ' |
Other (income) expense, net | 0 | 0 | 0 | 0 | ' |
Income (loss) before equity in earnings of subsidiaries and income taxes | 0 | 0 | 0 | 0 | ' |
Income tax expense (benefit) | 0 | 0 | 0 | 0 | ' |
Equity in earnings of subsidiaries, net of tax | -145.5 | -39.2 | -183.9 | -54.6 | ' |
Net income (loss) | -145.5 | -39.2 | -183.9 | -54.6 | ' |
Other comprehensive income (loss) | 0 | 0 | 0 | 0 | ' |
Total comprehensive income (loss) | -145.5 | -39.2 | -183.9 | -54.6 | ' |
Preferred stock dividends | 0 | 0 | 0 | 0 | ' |
Net income (loss) applicable to common shareowners | -145.5 | -39.2 | -183.9 | -54.6 | ' |
Condensed Consolidating Balance Sheets | ' | ' | ' | ' | ' |
Cash and cash equivalents | 0 | 0 | 0 | 0 | ' |
Receivables, net | 0 | ' | 0 | ' | 0 |
Other current assets | -0.3 | ' | -0.3 | ' | -0.7 |
Total current assets | -0.3 | ' | -0.3 | ' | -0.7 |
Property, plant and equipment, net | 0 | ' | 0 | ' | 0 |
Investment in CyrusOne | 0 | ' | 0 | ' | 0 |
Goodwill and intangibles, net | 0 | ' | 0 | ' | 0 |
Investments in and advances to subsidiaries | -1,713 | ' | -1,713 | ' | -1,623.20 |
Other noncurrent assets | -154.6 | ' | -154.6 | ' | -167.8 |
Total assets | -1,867.90 | ' | -1,867.90 | ' | -1,791.70 |
Current portion of long-term debt | 0 | ' | 0 | ' | 0 |
Accounts payable | 0 | ' | 0 | ' | 0 |
Other current liabilities | 0 | ' | 0 | ' | 0.1 |
Total current liabilities | 0 | ' | 0 | ' | 0.1 |
Long-term debt, less current portion | 0 | ' | 0 | ' | 0 |
Other noncurrent liabilities | -154.9 | ' | -154.9 | ' | -168.6 |
Intercompany payables | -337 | ' | -337 | ' | -429.5 |
Total liabilities | -491.9 | ' | -491.9 | ' | -598 |
Shareowners' (deficit) equity | -1,376 | ' | -1,376 | ' | -1,193.70 |
Total liabilities and shareowners' equity (deficit) | -1,867.90 | ' | -1,867.90 | ' | -1,791.70 |
Condensed Consolidating Statements of Cash Flows | ' | ' | ' | ' | ' |
Cash flows (used in) provided by operating activities | ' | ' | 0 | 0 | ' |
Capital expenditures | ' | ' | 0 | 0 | ' |
Proceeds from Sale of CyrusOne | ' | ' | 0 | ' | ' |
Dividends received from CyrusOne | ' | ' | 0 | 0 | ' |
Proceeds from sale of assets | ' | ' | 0 | 0 | ' |
Cash divested from deconsolidation of CyrusOne | ' | ' | ' | 0 | ' |
Other investing activities | ' | ' | 0 | 0 | ' |
Cash flows used in investing activities | ' | ' | 0 | 0 | ' |
Funding between Parent and subsidiaries, net | ' | ' | 0 | 0 | ' |
Borrowings on revolving facilities, net | ' | ' | 0 | 0 | ' |
Repayment of debt | ' | ' | 0 | 0 | ' |
Proceeds from exercise of options and warrants | ' | ' | 0 | 0 | ' |
Other financing activities | ' | ' | 0 | 0 | ' |
Cash flows provided by (used in) financing activities | ' | ' | 0 | 0 | ' |
(Decrease) increase in cash and cash equivalents | ' | ' | 0 | 0 | ' |
Cash and cash equivalents at beginning of period | ' | ' | 0 | 0 | ' |
Cash and cash equivalents at end of period | $0 | $0 | $0 | $0 | ' |